Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001326190-25-000017
Filing Date
2025-02-27
Accepted
2025-02-27 16:36:16
Documents
5
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20250227xs8.htm S-8 74875
2 EX-5.1 tmb-20250227xex5d1.htm EX-5.1 8570
3 EX-23.1 tmb-20250227xex23d1.htm EX-23.1 2490
4 EX-FILING FEES tmb-20250227xexfees.htm EX-FILING FEES 20247
5 GRAPHIC tmb-20250227xex5d1001.jpg GRAPHIC 4765
  Complete submission text file 0001326190-25-000017.txt   114160
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285350 | Film No.: 25679832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)